Ophthalmic Eye Drops Franchise in Ahmedabad

Antibiotic Steroid Eye Drops Supplier in Mumbai

Eye Infection Treatment Drops Distributor in Delhi

Ophthalmic Product Manufacturer in Bangalore

Eye Care Medicine Stockist in Hyderabad
Ophthalmic Product Exporter in Chandigarh

Home/Products /moxifloxacin-0-point-5-w-v-difluprednate-0-point-05-w-v-eye-ear-drop

About the Product

Description


Moxifloxacin 0.5% + Difluprednate 0.05% Eye Drops are indicated for the treatment of bacterial eye infections accompanied by moderate to severe inflammation, including postoperative ocular conditions.

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic that effectively eliminates causative bacteria, while difluprednate is a powerful corticosteroid that rapidly reduces inflammation, pain, redness, and swelling.

This advanced combination is widely prescribed in infective-inflammatory ocular disorders where strong anti-inflammatory action along with reliable antibacterial coverage is clinically essential.

With its fast symptom relief and high therapeutic reliability, this formulation encourages repeat prescriptions, strengthens treatment outcomes, and helps build a loyal customer base by consistently meeting ophthalmic care expectations.

Common side effects may include transient eye irritation, burning sensation, blurred vision, or redness. Rarely, prolonged use may lead to increased intraocular pressure, delayed wound healing, cataract formation, or secondary infections.

Moxolunic DF Eye Drops are indicated for severe steroid-responsive inflammatory ocular conditions with suspected or confirmed bacterial infection, including post-operative eye inflammation, uveitis, conjunctivitis, and other bacterial eye infections as advised by an ophthalmologist.

For ophthalmic use only. Use strictly under medical supervision. Avoid touching the dropper tip to prevent contamination. Prolonged or inappropriate use may increase the risk of glaucoma or other steroid-related complications. Discontinue use and consult an eye specialist if severe irritation or vision changes occur.

Store below 25°C in a cool, dry place. Protect from light. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Eye/Ear Drops in the PCD pharma franchise market?

Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Eye/Ear Drops have strong demand in the ophthalmology, ENT, and specialty eye care segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced eye and ear care portfolios.

Why should medical distributors include Moxifloxacin + Difluprednate Eye/Ear Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management with associated inflammation under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic effective against a wide range of susceptible bacteria Difluprednate 0.05% w/v is a corticosteroid that helps reduce inflammation, redness, swelling, and discomfort Commonly prescribed for ocular infections, post-operative eye care, and inflammatory eye conditions where antibacterial coverage is required, as advised by healthcare professionals Helps manage both infection and inflammation through a dual-action approach Sterile eye/ear drop formulation allows targeted local administration Frequently used in ophthalmology clinics, hospitals, and surgical eye care settings Widely prescribed by ophthalmologists, ENT specialists, and healthcare professionals This strengthens a comprehensive ophthalmology and specialty eye care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Eye/Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, growing ophthalmology market opportunities, repeat purchases, reliable supply chain support, and attractive margins in the specialty eye care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.